Sarah N Gibbs

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Sickle Cell Disease

Cross Sectional

Clinical Practice

Top Venues

ClinicoEconomics and outcomes research : CEOR

JCO precision oncology

Journal of healthcare leadership

Research and practice in thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Morie Gertz, Rafat Abonour, Sarah N Gibbs, Muriel Finkel, Heather Landau, Suzanne Lentzsch, Grace Lin, Anuj Mahindra, Tiffany Quock, Cara Rosenbaum, Michael Rosenzweig, Surbhi Sidana, Sascha A Tuchman, Ronald Witteles, Irina Yermilov, Michael S Broder
Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Sarah N Gibbs, Desi Peneva, Gebra Cuyun Carter, Melanie R Palomares, Snehal Thakkar, David W Hall, Hannah Dalglish, Cynthia Campos, Irina Yermilov
Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer. JCO precision oncology 7 (2023)
Michael S Broder, Sarah N Gibbs, Irina Yermilov
An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19. Journal of healthcare leadership 14 (2022)
Adam Cuker, Jenny M Despotovic, Rachael F Grace, Caroline Kruse, Michele P Lambert, Howard A Liebman, Roger M Lyons, Keith R McCrae, Vinod Pullarkat, Jeffrey S Wasser, David Beenhouwer, Sarah N Gibbs, Irina Yermilov, Michael S Broder
Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method. Research and practice in thrombosis and haemostasis 5 (1) (2020)
Nirmish R Shah, David Beenhouwer, Michael S Broder, Lanetta Bronte-Hall, Laura M De Castro, Sarah N Gibbs, Victor R Gordeuk, Julie Kanter, Elizabeth S Klings, Thokozeni Lipato, Deepa Manwani, Brigid Scullin, Irina Yermilov, Wally R Smith
Development of a Severity Classification System for Sickle Cell Disease. ClinicoEconomics and outcomes research : CEOR 12 (2020)